AI filing briefs

21Shares XRP ETF (TOXR)

TOXR 8-K filings, explained

Every material Form 8-K 21Shares XRP ETF has filed with the SEC since July 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs on record2since Jul 07, 2026
Latest filingAug 26, 2026legal/regulatory
High impact (4-5)0of 2 briefs
ToneNeutral2
legal/regulatory 1product/contract 1

2026

Aug 26, 4:20 PM ET

21Shares XRP ETF switches XRP index to FTSE benchmark from August 27, 2026

Neutral legal/regulatory Written later 1.015.03

The fund's sponsor signed a licensing agreement with FTSE International for the FTSE XRP Index, which will replace the CME CF XRP-Dollar Reference Rate for valuing shares and calculating net asset value starting August 27, 2026. The filing also amends the sponsor fee to be paid at least quarterly rather than weekly, and updates the trust agreement to reflect these changes, which the filing says do not materially affect shareholder rights.

  • Benchmark change follows CF Benchmarks licensing termination effective August 31, 2026, with the FTSE switch beginning August 27, 2026.
  • FTSE XRP Index licence is expected to have a one-year initial term, renewing automatically for one-year periods.
  • Sponsor fee payment timing changed from weekly in arrears to at least quarterly in arrears, still payable in XRP.
  • Fourth Amended and Restated Trust Agreement signed August 26, 2026 with CSC Delaware Trust Company as trustee.
Read the filing on SEC.gov ↗
Jul 7, 4:31 PM ET

21Shares XRP ETF to end CF Benchmarks pricing license, effective Aug. 31, 2026

Neutral product/contract Written later 1.02

The Sponsor, 21Shares US LLC, notified CF Benchmarks on June 30, 2026 that it is terminating the licensing agreement for the XRP pricing benchmark used to value the Trust's shares and calculate its net asset value, effective August 31, 2026. The Sponsor plans to replace it with a licensing agreement with FTSE International Limited on or about August 24, 2026, as part of a broader move to a new benchmark provider.

  • Notice of termination given to CF Benchmarks on June 30, 2026; termination effective August 31, 2026
  • Terminated agreement covers the CME CF XRP-Dollar Reference Rate, New York Variant, used daily for share valuation and NAV
  • Sponsor intends to license FTSE index data on or about August 24, 2026, with a one-year initial term that renews automatically
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every 21Shares XRP ETF filing is on SEC EDGAR ↗. 8-K briefs of other companies →